BARCLAYS PLC - 08 Aug 2022 Form 3 Insider Report for Minerva Neurosciences, Inc. (NERV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
10 Aug 2022, 14:07:07 UTC
Prior SEC filing
19 Jul 2022
Next SEC filing
16 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Suejean Mott

Key filing fact

BARCLAYS PLC filed Form 3 for Minerva Neurosciences, Inc. (NERV) on 10 Aug 2022.

Key facts

  • This page summarizes BARCLAYS PLC's Form 3 filing for Minerva Neurosciences, Inc. (NERV).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Aug 2022, 14:07.

Change

  • Previous filing in this sequence was filed on 19 Jul 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NERV holding

Common Stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
408,430
Date
08 Aug 2022
Ownership
By Barclays Bank PLC
NERV holding

Common Stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
196,800
Date
08 Aug 2022
Ownership
By Barclays Capital Inc.
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

(a) Beneficially owned ordinary shares are comprised in Units, each consisting of one ordinary share (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (3) Barclays Capital, Inc. (controlled by Barclays PLC) (c) Address of Principal Business Office or, if non, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (3) Barclays Capital, Inc. 745 7th Avenue New York, New York 10019 United States

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .